Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

5.80
+0.830016.70%
Volume:303.79K
Turnover:1.70M
Market Cap:291.56M
PE:-3.31
High:5.82
Open:4.96
Low:4.95
Close:4.97
Loading ...
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 04, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2023

Major Issues Report

8-K - Current report
Dec 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership